Literature DB >> 6733020

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

A E Lykkesfeldt, J K Larsen, I J Christensen, P Briand.   

Abstract

The effect of 10(-6) M tamoxifen on MCF-7 cells adapted to growth in 0.5% foetal calf serum has been studied. The growth inhibitory effect of this tamoxifen concentration was abolished by simultaneous addition of 10(-8) M oestradiol, indicating that tamoxifen may exert its effect via binding to the oestrogen receptor. Flow cytometric cell cycle analysis of tamoxifen-treated cultures showed an increase in the proportion of cells in the G1 phase of the cell cycle. By exposing the cells to BUdR before flow cytometry the growth fraction was determined and found to be dramatically decreased in tamoxifen-treated cultures. Cells were not only arrested in the G1 phase but also in the G2 phase of the cell cycle. A few colonies of MCF-7 cells were resistant to 10 days treatment with 10(-6) M tamoxifen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733020      PMCID: PMC1976853          DOI: 10.1038/bjc.1984.113

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  A bromodeoxyuridine (BUdR)-mithramycin technique for detecting cycling and non-cycling cells by flow microfluorometry.

Authors:  D E Swartzendruber
Journal:  Exp Cell Res       Date:  1977-10-15       Impact factor: 3.905

2.  A detergent-citric acid technique for isolating nuclear and cytoplasmic fractions containing undegraded RNA from cells of Xenopus laevis.

Authors:  L Miller
Journal:  Anal Biochem       Date:  1979-11-15       Impact factor: 3.365

Review 3.  Tamoxifen in advanced breast cancer.

Authors:  H Mouridsen; T Palshof; J Patterson; L Battersby
Journal:  Cancer Treat Rev       Date:  1978-09       Impact factor: 12.111

4.  Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

5.  The binding of tamoxifen to human mammary carcinoma cytosol.

Authors:  R L Sutherland; L C Murphy
Journal:  Eur J Cancer       Date:  1980-09       Impact factor: 9.162

6.  High-affinity anti-oestrogen binding site distinct from the oestrogen receptor.

Authors:  R L Sutherland; L C Murphy; M San Foo; M D Green; A M Whybourne; Z S Krozowski
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

Review 7.  Therapeutic effect of tamoxifen related to estrogen receptor level.

Authors:  C Rose; S M Thorpe; J Løber; J L Daenfeldt; T Palshof; H T Mouridsen
Journal:  Recent Results Cancer Res       Date:  1980

8.  Long-term storage of samples for flow cytometric DNA analysis.

Authors:  L L Vindeløv; I J Christensen; N Keiding; M Spang-Thomsen; N I Nissen
Journal:  Cytometry       Date:  1983-03

9.  Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.

Authors:  K B Horwitz; M B Mockus; B A Lessey
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

10.  Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.

Authors:  H Nawata; D Bronzert; M E Lippman
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  13 in total

1.  Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

Authors:  R Grenman; K M Laine; P J Klemi; S Grenman; D J Hayashida; H Joensuu
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.

Authors:  Mengyuan Du; Xujuan Yang; James A Hartman; Paul S Cooke; Daniel R Doerge; Young H Ju; William G Helferich
Journal:  Carcinogenesis       Date:  2012-01-20       Impact factor: 4.944

3.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

4.  Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.

Authors:  Penn Muluhngwi; Kirsten Richardson; Joshua Napier; Eric C Rouchka; Justin L Mott; Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2017-01-28       Impact factor: 4.102

5.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

6.  4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro.

Authors:  J N Sarkaria; E M Miller; C J Parker; V C Jordan; R T Mulcahy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Effects of tamoxifen and 4-hydroxytamoxifen on synchronized cultures of the human breast cancer cell line MCF-7.

Authors:  W B Butler; W H Kelsey
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

8.  Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

9.  Altered radiation responses of breast cancer cells resistant to hormonal therapy.

Authors:  Lidiya Luzhna; Anne E Lykkesfeldt; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-01-30

10.  Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.

Authors:  A D Baildam; J Zaloudik; A Howell; D M Barnes; M Moore; R A Sellwood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.